SCHEMBL2233201

SCHEMBL2233201

CC(C)c1ccc(Oc2ccc3cc(CO)ccc3n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPBWR1 P48145 1/20 0.41
MCHR1 Q99705 1/20 0.41
CYP1A2 P05177 1/20 0.38
CYP2E1 P05181 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C8 P10632 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2B6 P20813 1/20 0.38
CYP2C19 P33261 1/20 0.38
SCN9A Q15858 8/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
TEC P42680 1/20 0.35
SCN7A Q01118 2/20 0.35
KCNH2 Q12809 2/20 0.35
SCN5A Q14524 1/20 0.35
SCN2A Q99250 1/20 0.35
SCN8A Q9UQD0 1/20 0.35
ABCB11 O95342 1/20 0.35
KDM4E B2RXH2 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2232086 0.85 MAP4K4 (0.44) CYP1A2CYP3A4KDM4EALDH1A1
SCHEMBL2232609 0.78 HTR6 (0.48) SCN9ASCN10ASCN7AKCNH2SCN5A
SCHEMBL13582633 0.77 ALDH1A1 (0.47) ALDH1A1LTA4H
SCHEMBL2236064 0.76 TYR (0.46) NPBWR1MCHR1CYP1A2CYP3A4SCN9A
SCHEMBL2232061 0.76 PDE4B (0.57) CYP1A2CYP3A4CYP2C9CYP2C19KDM4E
SCHEMBL21458325 0.75 MTNR1A (0.47) KDM4EALDH1A1
SCHEMBL31731406 0.75 MTNR1A (0.47) KDM4EALDH1A1
SCHEMBL10309472 0.75 AKR1C3 (0.49) CYP1A2CYP2D6KCNH2ABCB11ALDH1A1
SCHEMBL3720364 0.73 NCF1 (0.38) CYP3A4KDM4EALDH1A1
SCHEMBL22095444 0.72 HSD17B10 (0.39) CYP1A2TECALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2528897-B9 DI-SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMA CO LTD (JP) 2015-04-22 EP disclosed
EP-2528897-B1 DI-SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMA CO LTD (JP) 2014-10-15 EP disclosed
EP-2528897-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS Otsuka Pharmaceutical Co., Ltd. (JP) 2012-12-05 EP disclosed
CN-102791690-A Di-substituted pyridine derivatives as anticancers OTSUKA PHARMA CO LTD 2012-11-21 CN disclosed
WO-2011093524-A9 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-12-01 WO disclosed
WO-2011093524-A1 DI - SUBSTITUTED PYRIDINE DERIVATIVES AS ANTICANCERS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-04 WO disclosed